Cargando…
Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer
The purpose of this work is to analyze preoperative serum aspartate aminotransferase (AST) levels and their effect on the prognosis of patients with non-small cell lung cancer (NSCLC) after surgical operation. These analyses were performed retrospectively in patients with NSCLC followed by surgery;...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037752/ https://www.ncbi.nlm.nih.gov/pubmed/27598151 http://dx.doi.org/10.3390/ijms17091474 |
_version_ | 1782455806032084992 |
---|---|
author | Chen, Shu-Lin Xue, Ning Wu, Mian-Tao Chen, Hao He, Xia Li, Jian-Pei Liu, Wan-Li Dai, Shu-Qin |
author_facet | Chen, Shu-Lin Xue, Ning Wu, Mian-Tao Chen, Hao He, Xia Li, Jian-Pei Liu, Wan-Li Dai, Shu-Qin |
author_sort | Chen, Shu-Lin |
collection | PubMed |
description | The purpose of this work is to analyze preoperative serum aspartate aminotransferase (AST) levels and their effect on the prognosis of patients with non-small cell lung cancer (NSCLC) after surgical operation. These analyses were performed retrospectively in patients with NSCLC followed by surgery; participants were recruited between January 2004 and January 2008. All clinical information and laboratory results were collected from medical records. We explored the association between preoperative serum AST and recurrence-free survival (RFS), and the overall survival (OS) of NSCLC patients. Kaplan–Meier analysis and Cox multivariate analysis, stratified by the AST median value, were used to evaluate the prognostic effect. A chi-squared test was performed to compare clinical characteristics in different subgroups. A p-value of ≤0.05 was considered to be statistically significant. A total of 231 patients were enrolled. The median RFS and OS were 22 and 59 months, respectively. The AST levels were divided into two groups, using a cut-off value of 19 U/L: High AST (>19 U/L), n = 113 vs. low AST (≤19 U/L), n = 118. Multivariate analysis indicated that preoperative serum AST > 19 U/L (hazard ratio (HR) = 0.685, 95% confidence interval (CI): 0.493–0.994, p = 0.046 for RFS, HR = 0.646, 95% CI: 0.438–0.954, p = 0.028 for OS) was an independent prognostic factor for both RFS and OS. High preoperative serum AST levels may serve as a valuable marker to predict the prognosis of NSCLC after operation. |
format | Online Article Text |
id | pubmed-5037752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-50377522016-09-29 Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer Chen, Shu-Lin Xue, Ning Wu, Mian-Tao Chen, Hao He, Xia Li, Jian-Pei Liu, Wan-Li Dai, Shu-Qin Int J Mol Sci Article The purpose of this work is to analyze preoperative serum aspartate aminotransferase (AST) levels and their effect on the prognosis of patients with non-small cell lung cancer (NSCLC) after surgical operation. These analyses were performed retrospectively in patients with NSCLC followed by surgery; participants were recruited between January 2004 and January 2008. All clinical information and laboratory results were collected from medical records. We explored the association between preoperative serum AST and recurrence-free survival (RFS), and the overall survival (OS) of NSCLC patients. Kaplan–Meier analysis and Cox multivariate analysis, stratified by the AST median value, were used to evaluate the prognostic effect. A chi-squared test was performed to compare clinical characteristics in different subgroups. A p-value of ≤0.05 was considered to be statistically significant. A total of 231 patients were enrolled. The median RFS and OS were 22 and 59 months, respectively. The AST levels were divided into two groups, using a cut-off value of 19 U/L: High AST (>19 U/L), n = 113 vs. low AST (≤19 U/L), n = 118. Multivariate analysis indicated that preoperative serum AST > 19 U/L (hazard ratio (HR) = 0.685, 95% confidence interval (CI): 0.493–0.994, p = 0.046 for RFS, HR = 0.646, 95% CI: 0.438–0.954, p = 0.028 for OS) was an independent prognostic factor for both RFS and OS. High preoperative serum AST levels may serve as a valuable marker to predict the prognosis of NSCLC after operation. MDPI 2016-09-03 /pmc/articles/PMC5037752/ /pubmed/27598151 http://dx.doi.org/10.3390/ijms17091474 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Shu-Lin Xue, Ning Wu, Mian-Tao Chen, Hao He, Xia Li, Jian-Pei Liu, Wan-Li Dai, Shu-Qin Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer |
title | Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer |
title_full | Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer |
title_fullStr | Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer |
title_full_unstemmed | Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer |
title_short | Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer |
title_sort | influence of preoperative serum aspartate aminotransferase (ast) level on the prognosis of patients with non-small cell lung cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037752/ https://www.ncbi.nlm.nih.gov/pubmed/27598151 http://dx.doi.org/10.3390/ijms17091474 |
work_keys_str_mv | AT chenshulin influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT xuening influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT wumiantao influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT chenhao influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT hexia influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT lijianpei influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT liuwanli influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer AT daishuqin influenceofpreoperativeserumaspartateaminotransferaseastlevelontheprognosisofpatientswithnonsmallcelllungcancer |